Ankylosing spondylitis treatment market is projected to grow at a considerable CAGR of around 5% during the forecast period (2020-2026). The growing incidence and prevalence of ankylosing spondylitis due to a sedentary lifestyle along with the introduction of novel products are expected to drive market growth over the forecast period. The increasing per capita income, improving healthcare infrastructure, and growing investment in R&D of novel therapies are the other factors that are contributing towards the growth of the global market. The HealthWell Foundation, an independent non-profit organization had launched a new program to assist patients who have been diagnosed with ankylosing spondylitis.
Get Free Sample link @ https://www.omrglobal.com/request-sample/ankylosing-spondylitis-treatment-market
The presence of such awareness programs to make people aware related to the treatment of ankylosing spondylitis is further contributing to the growth of the ankylosing spondylitis treatment market. However, patent loss, the launch of biosimilars, and the dearth of trained rheumatologists with proper skill and knowledge to perform proper treatment act as major restraints for the growth of the market across the globe.
A full report of Global Ankylosing Spondylitis Treatment Market available @ https://www.omrglobal.com/industry-reports/ankylosing-spondylitis-treatment-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Ankylosing Spondylitis Treatment Market by Drug
- Secukinumab
- Adalimumab
- Golimumab
- Infliximab
- Etanercept
- Certolizumab Pegol
- Other
Regional Analysis
- North America
- US
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- AbbVie, lnc.
- Allergen, Inc.
- Amgen, Inc.
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb, Co.
- Cadila Healthcare, Ltd.
- Eli Lilly and Co.
- Endo Health Solutions, Inc.
- Hoffmann-La Roche, Ltd.
- Ferring B.V.
- GlaxoSmithKline Plc
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
- Purdue Pharma L.P.
- Sanofi S.A.
- Torrent Pharmaceuticals, Ltd.
- Valeant Pharmaceuticals International Inc.
The Report Covers
- Market value data analysis of 2019 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global ankylosing spondylitis treatment market. Based on the availability of data, information related to the products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/ankylosing-spondylitis-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
